SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6%
Thu, 28 May

SUN PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m71,63981,54981,8490.4%14.3%
Other incomeRs m2,8151,1991,022-14.7%-63.7%
TurnoverRs m74,45582,74782,8720.2%11.3%
ExpensesRs m61,47163,13568,2198.1%11.0%
Gross profitRs m10,16818,41411,024-40.1%8.4%
DepreciationRs m4,5415,4705,7545.2%26.7%
InterestRs m1,500630518-17.8%-65.5%
Profit before taxRs m6,94213,5135,774-57.3%-16.8%
TaxRs m-2883,276831-74.6%
Profit after taxRs m7,23110,2374,944-51.7%-31.6%
Gross profit margin%14.222.613.5
Effective tax rate%-4.124.214.4
Net profit margin%9.712.46.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 14.3% on a year-on-year (YoY) basis. The expenses were up by 11.0% YoY during the same period.
  • The company's operating profit increased by 8.4% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 13.5% in 4QFY20 as against 14.2% in 4QFY19.
  • Depreciation charges increased by 26.7% and finance costs declined by 65.5% YoY, respectively.
  • Other income declined by 63.7% YoY during the quarter.
  • Net profit for the quarter declined by 31.6% YoY. Net profit margins during the quarter declined from 9.7% in 4QFY19 to 6.0% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 8.1% QoQ during the same period.
  • The company's operating profit declined by 40.1% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 13.5% in 4QFY20 as against 22.6% in 3QFY19.
  • Net profit for the quarter declined by 51.7% QoQ, while net profit margins declined from 12.4% in 3QFY19 to 6.0% in 4QFY20.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

Revealed: Top 3 Stocks for 2020 and Beyond

SUN PHARMA Share Price Performance

Over the last one year,SUN PHARMA share price has moved up from Rs 412.9 to Rs 458.0, registering a Gain of Rs 45.1 or around 10.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,269.3 (down 0.1%). Over the last one year it has moved up from 13,371.0 to 15,269.3, a gain of 1,898 points (up 14.2%).

Overall, the S&P BSE SENSEX is down 19.2% over the year.

Current Valuations

At the current price of Rs 458.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 26.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.7 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Aug 11, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS